Ben Bronstein, Director at Aldeyra Therapeutics, Inc. (ALDX), bought 12,500 shares at $8.00 ($100K) on 2014-05-07, disclosed to the SEC on 2014-05-08.
Open-market purchase of $100k ALDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |